Attention Zenas BioPharma Investors: Class Action Lawsuit Filed – Key Deadline Approaches!

Investors in Zenas BioPharma, Inc. are being urged to take action as the law firm Levi & Korsinsky has announced a class action lawsuit pertaining to the company. This lawsuit comes in light of allegations that critical information about Zenas BioPharma was not disclosed adequately, potentially affecting shareholders’ decisions. Shareholders are advised to examine their eligibility to participate in the lawsuit. The action has been initiated in response to claims that Zenas BioPharma may have misrepresented key details that could influence stock values. Investors are encouraged to consider the implications of these allegations on their … Read more

Pharmaceutical Company PDL BioPharma Files Lawsuit Against Eli Lilly and Company Over Alzheimer’s Treatment Compensation

INDIANAPOLIS, IN — Nevada-based company PDL BioPharma, Inc. has filed a lawsuit against Eli Lilly and Company in the U.S. District Court for the Southern District of Indiana. PDL alleges that Eli Lilly used its technology to develop an Alzheimer’s disease treatment without compensating PDL. According to the lawsuit filed on December 21, 2023, PDL claims that Eli Lilly used its antibody humanization technology to create donanemab, a treatment for Alzheimer’s. Donanemab is expected to receive FDA approval in the first quarter of 2024. The lawsuit refers to a 2000 agreement between Eli Lilly and … Read more